← Back to headlines
Ozempic-Maker Chooses Singapore for Piloting Diabetes and Obesity Treatments
The manufacturer of Ozempic views Singapore as a strategic platform to pilot new treatments for diabetes and obesity.
1 May, 21:02 — 1 May, 21:02
Sources
Showing 1 of 1 sources
